Increasing Access to Antiretroviral Therapy for the Prevention and Treatment of HIV in Infants, Children, and Youth in the United States: Policy Statement.

Authors

Rosemary Olivero, Corewell Health West
Susan Gillespie

Document Type

Article

Publication Date

2025

Publication Title

Pediatrics

Abstract

Although significant progress has been made in prevention and treatment of HIV in the United States, nationally and globally, infants and children younger than 13 years have less access to optimal antiretroviral therapy compared with youth (13-24 years) and adults, which can negatively affect health outcomes for those with HIV. Despite youth having nearly as many antiretroviral options for HIV management as adults, optimal HIV management in youth is challenged by psychosocial and structural barriers that result in poor access to HIV prevention and care. Significant barriers remain in providing equitable access to optimal HIV treatment and prevention services in the pediatric population.

Volume

156

Issue

2

First Page

e2025072718

Last Page

e2025072718

Recommended Citation

Olivero R, Gillespie S. Increasing access to antiretroviral therapy for the prevention and treatment of HIV in infants, children, and youth in the United States: Policy statement. Pediatrics. 2025;156(2). doi: 10.1542/peds.2025-072718. PMID: 40685151.

Comments

Helen DeVos Children's Hospital

DOI

10.1542/peds.2025-072718

ISSN

1098-4275

PubMed ID

40685151